N-(1H-Benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-butanediamine hydrochloride (1:1)(CAS: 880549-30-4)

This compound is subject to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous materials, REACH regulations in the EU for registration, evaluation, authorization, and restriction of chemicals, and may be controlled by the FDA and EPA in the US under specific circumstances. Ensure compliance with local and international regulations regarding its transportation, storage, and disposal.

Synthesizers may consider using analogs such as N-(1H-Benzimidazol-2-ylmethyl)-N-(5,6,7,8-tetrahydroquinolin-8-yl)-1,4-butanediamine or isomers of similar chemical structures. Other alternatives include substituting with common reagents like 1,4-butanediamine and varying the benzimidazole or quinoline substituents, depending on the desired properties of the final product.

The market for this compound shows increasing interest in its applications for pharmaceuticals and agrochemicals, driven by its potential as an intermediate or active ingredient. Research trends focus on exploring its biological activities, such as antimicrobial and antiparasitic properties, and developing more efficient synthesis methods. Cost trends are influenced by raw material availability and market demand.

Waste containing this compound should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration can be used for safe disposal, ensuring all regulations are followed. Environmental protection measures include neutralizing the waste to minimize environmental impact and disposing of it at designated hazardous waste facilities.